Lori Macomber is EVP, CFO & Treasurer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 160,000 shares of KPTI, which is worth approximately $99,200. The most recent transaction as insider was on Jan 31, 2025, when has been sold 160,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K
n/a 3M change
n/a 12M change
Total Value Held $99,200

Lori Macomber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
BUY
Grant, award, or other acquisition
-
160,000 Added 50.0%
160,000 Common Stock
LM

Lori Macomber

EVP, CFO & Treasurer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI